中国生物制药 (01177.HK)

+ 收藏

财务摘要(报告期)(中国生物制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
原始币种(元) 人民币人民币人民币人民币人民币
每股指标:
 每股收益EPS基本(元) 0.160.130.070.140.10
 每股净资产(元) 1.751.621.591.581.61
 每股经营现金净流量(元) 0.160.320.140.330.21
 每股现金流量净额(元) -0.16-0.07-0.29-0.05-0.19
 每股营业收入(元) 0.841.390.811.530.81
盈利能力:
 销售毛利率(%) 82.0880.9578.6879.8680.52
 销售净利率(%) 29.0219.4617.6717.3820.95
 净资产收益率平均(%) 9.537.744.218.476.35
 总资产净利率(%) 4.633.651.944.083.06
 投入资本回报率ROIC(%) 6.335.172.755.894.21
收益质量:
 营业利润/利润总额(%) 106.83118.87116.24110.2591.11
 税项/利润总额(%) 16.9914.7416.2813.4315.22
 经营活动产生的现金流量净额/营业收入(%) 19.3923.1517.4821.7725.99
资本结构:
 资产负债率(%) 36.8539.9944.4640.7740.33
 权益乘数 1.581.671.801.691.68
 产权比率 0.750.830.970.880.87
 流动资产/总资产(%) 37.8137.4341.1040.4838.80
 非流动资产/总资产(%) 62.1962.5758.9059.5261.20
 流动负债/负债合计(%) 89.2988.8892.0677.1462.11
 非流动负债/负债合计(%) 10.7111.127.9422.8637.89
 归属母公司股东的权益/投入资本(%) 67.2065.6063.0167.9162.12
偿债能力:
 流动比率 1.151.051.001.291.55
 速动比率 1.070.960.931.171.42
 货币资金/流动负债(%) 38.9541.8143.0959.8847.76
 营业利润/流动负债(%) 17.5928.4513.9531.6221.03
 经营活动产生的现金流量净额/流动负债(%) 14.0326.839.9431.0924.28
 归属母公司股东的权益/负债合计(%) 133.61119.81102.77113.88115.37
 经营活动产生的现金流量净额/负债合计(%) 12.5223.859.1523.9915.08
 营业利润/负债合计(%) 15.7125.2812.8424.3913.06
成长能力:
 总资产同比增长率(%) 1.62-0.721.095.8215.53
 每股净资产同比增长率(%) 9.632.51-0.71-1.6623.25
 总负债同比增长率(%) -15.76-2.6311.4314.494.35
 基本每股收益同比增长率(%) 141.74-7.83-34.17-82.45-77.19
 归属母公司股东的权益同比增长率(%) 9.522.45-0.74-1.8022.94
 营业利润同比增长率(%) 8.2410.939.5621.33-3.39
 营业收入同比增长率(%) 11.140.670.557.145.85
 股东权益合计同比增长率(%) 15.530.60-5.900.5724.54
营运能力:
 存货周转率次(次) 1.492.311.502.721.45
 流动资产周转率次(次) 0.651.050.581.160.62
 固定资产周转率次(次) 1.973.311.953.862.09
 总资产周转率次(次) 0.240.410.240.460.24
衍生指标:
 现金及现金等价物净增加额TTM(元) 1,143,547,000.00-1,240,231,000.00-2,936,477,000.00-992,054,000.00-1,394,089,000.00
 利润总额TTM(元) 5,969,800,000.005,409,906,000.005,248,159,000.005,778,604,000.0011,348,770,000.00
 毛利TTM(元) 22,555,242,000.0021,209,532,000.0022,771,295,000.0022,984,902,000.0022,162,740,000.00
 投入资本(元) 48,877,570,000.0046,457,457,000.0047,594,188,000.0043,801,554,000.0048,635,713,000.00
 经营活动产生的现金流量净额TTM(元) 6,473,106,000.006,065,734,000.004,987,332,000.006,265,155,000.006,979,681,000.00
 总营业收入TTM(元) 27,790,140,000.0026,199,409,000.0028,863,711,000.0028,780,412,000.0027,701,313,000.00
 归属母公司净利润TTM(元) 4,090,317,000.002,331,939,000.001,881,317,000.002,543,570,000.008,049,109,000.00
 所得税TTM(元) 913,368,000.00797,267,000.00729,338,000.00775,986,000.001,192,360,000.00
截止日期(元) 2024-06-302023-12-312023-06-302022-12-312022-06-30
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院